| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Body Mass Index Progression, Development of Complications and Healthcare Costs Over 8 Years in UK Individuals Living With Overweight/Obesity
|
Busetto, Luca
|
|
|
42 |
9 |
p. 4626-4640
|
artikel
|
| 2 |
Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn’s Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey
|
Rubin, David T.
|
|
|
42 |
9 |
p. 4510-4526
|
artikel
|
| 3 |
Burden of Atopic Dermatitis in Patients Initiating Systemic Therapies in the United States
|
Zirwas, Matthew
|
|
|
42 |
9 |
p. 4447-4463
|
artikel
|
| 4 |
Challenges and Opportunities for Improving Management of Patients with nAMD and DME in China: Insights from a Global Survey on Anti-VEGF Therapy
|
Sun, Xiaodong
|
|
|
42 |
9 |
p. 4390-4402
|
artikel
|
| 5 |
Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy
|
Wedzicha, Jadwiga A.
|
|
|
42 |
9 |
p. 4432-4446
|
artikel
|
| 6 |
Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
|
Taylor, Peter C.
|
|
|
42 |
9 |
p. 4717-4719
|
artikel
|
| 7 |
Correction to: Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study
|
Lugogo, Njira L.
|
|
|
42 |
9 |
p. 4724-4725
|
artikel
|
| 8 |
Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study
|
Lebwohl, Mark G.
|
|
|
42 |
9 |
p. 4720-4723
|
artikel
|
| 9 |
Development of the Pediatric Weight Questionnaire (PWQ™) for Children and Adolescents with Obesity
|
Boye, Kristina S.
|
|
|
42 |
9 |
p. 4464-4485
|
artikel
|
| 10 |
Efficacy and Safety Maintained up to 3 Years in Adults with Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan
|
de Castro, Carlos
|
|
|
42 |
9 |
p. 4641-4658
|
artikel
|
| 11 |
Efficacy and Safety of TV-46000 and Second-Generation Long-Acting Injectable Antipsychotics for Schizophrenia: A Systematic Literature Review and Network Meta-Analysis of Randomized Controlled Trials
|
Franzenburg, Kelli R.
|
|
|
42 |
9 |
p. 4188-4209
|
artikel
|
| 12 |
Epidemiology and Steroid Dependency Reduction in Crohn’s Disease During the Biologics Era: A Nationwide Population-Based Study
|
Chen, Nai-Yu
|
|
|
42 |
9 |
p. 4318-4334
|
artikel
|
| 13 |
Ethnicity Risk and Exertional Rhabdomyolysis: A Narrative Review
|
Nguyen, Angela
|
|
|
42 |
9 |
p. 4131-4142
|
artikel
|
| 14 |
Evaluating the Compositional Quality of Probiotics Containing Bacillus clausii in India
|
Kesavelu, Dhanasekhar
|
|
|
42 |
9 |
p. 4571-4582
|
artikel
|
| 15 |
Evaluation of XSB-001 (Ranibizumab Biosimilar) Physicochemical and Biological Stability in Prepared Syringes for Intravitreal Injection
|
Björnestedt, Robert
|
|
|
42 |
9 |
p. 4597-4610
|
artikel
|
| 16 |
How to ESCAPE from Pain? An Observational Study on Improving Pain and Quality of Life with the Cannamedical® Hybrid Cannabis Extract
|
Wagner, Yvonne
|
|
|
42 |
9 |
p. 4367-4389
|
artikel
|
| 17 |
Integration of Generative AI with Human Expertise in HEOR: A Hybrid Intelligence Framework
|
Srivastava, Tushar
|
|
|
42 |
9 |
p. 4103-4130
|
artikel
|
| 18 |
Interferon in Liver Diseases: Recent Advances
|
Gao, Yuting
|
|
|
42 |
9 |
p. 4210-4223
|
artikel
|
| 19 |
Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration
|
Navarro-Compán, Victoria
|
|
|
42 |
9 |
p. 4706-4716
|
artikel
|
| 20 |
Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval
|
Khan, Aliya A.
|
|
|
42 |
9 |
p. 4270-4299
|
artikel
|
| 21 |
Matching-Adjusted Indirect Comparison of Sotorasib Versus Adagrasib in Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation
|
Chopra, Divyan
|
|
|
42 |
9 |
p. 4300-4317
|
artikel
|
| 22 |
Obstructive Sleep Apnea: An Evolving Therapeutic Landscape with an Emerging Role for Incretin-Based Therapies
|
Xu, Bolong
|
|
|
42 |
9 |
p. 4255-4269
|
artikel
|
| 23 |
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial
|
Zhao, Yan
|
|
|
42 |
9 |
p. 4527-4539
|
artikel
|
| 24 |
Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles
|
Hanson, Kent A.
|
|
|
42 |
9 |
p. 4556-4570
|
artikel
|
| 25 |
Pharmacokinetic Bioequivalence, Safety, and Immunogenicity of DMB-3115, an Ustekinumab Biosimilar, and EU- and US-Stelara in Healthy Adult Participants: A Randomized, Double-Blind, Single-Dose Study
|
Morita, Jun
|
|
|
42 |
9 |
p. 4681-4695
|
artikel
|
| 26 |
Pharmacokinetics and Safety of Ripretinib in Participants with Hepatic Impairment: A Phase 1 Study
|
Papinska, Anna
|
|
|
42 |
9 |
p. 4540-4555
|
artikel
|
| 27 |
Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)
|
Marotte, Hubert
|
|
|
42 |
9 |
p. 4659-4680
|
artikel
|
| 28 |
Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022–2023
|
Puig, Luis
|
|
|
42 |
9 |
p. 4224-4254
|
artikel
|
| 29 |
Real-World Prophylaxis Outcomes with rIX-FP and rFIXFc for Males with Hemophilia B: Pooled Analysis of Medical Chart Data from Germany and Italy
|
Oldenburg, Johannes
|
|
|
42 |
9 |
p. 4583-4596
|
artikel
|
| 30 |
Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan
|
Nangaku, Masaomi
|
|
|
42 |
9 |
p. 4486-4509
|
artikel
|
| 31 |
Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
|
Quaranta, Luciano
|
|
|
42 |
9 |
p. 4403-4417
|
artikel
|
| 32 |
Safety, Tolerability, and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients with Focal-Onset Seizures: Interim Analysis of a Phase 3 Open-Label Extension Trial
|
Fujimoto, Ayataka
|
|
|
42 |
9 |
p. 4335-4349
|
artikel
|
| 33 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Firsekibart, an Anti-interleukin-1β Monoclonal Antibody, in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
|
Liu, Hongzhong
|
|
|
42 |
9 |
p. 4611-4625
|
artikel
|
| 34 |
Survival Outcomes with Cilta-cel Versus Conventional Treatment Regimens for Patients with Lenalidomide-Refractory Multiple Myeloma Using Inverse Probability of Treatment Weighting
|
Fonseca, Rafael
|
|
|
42 |
9 |
p. 4418-4431
|
artikel
|
| 35 |
Systematic Review and Meta-analysis of Long-Term Nusinersen Effectiveness in Adolescents and Adults with Spinal Muscular Atrophy
|
Hagenacker, Tim
|
|
|
42 |
9 |
p. 4143-4160
|
artikel
|
| 36 |
Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen in Patients with Schizophrenia
|
Lauriello, John
|
|
|
42 |
9 |
p. 4350-4366
|
artikel
|
| 37 |
Trospium Chloride in the Treatment of Overactive Bladder Syndrome and Detrusor Overactivity
|
Truzzi, José C.
|
|
|
42 |
9 |
p. 4161-4187
|
artikel
|
| 38 |
When Primary Ciliary Dyskinesia Is Diagnosed in Utero: Insights from Two Families
|
Amirav, Israel
|
|
|
42 |
9 |
p. 4696-4705
|
artikel
|
Tijdschrift beschrijving